Chronic spontaneous urticaria or urticarial vasculitis?
- Authors: Dorofeeva I.V.1, Danilycheva I.V.1, Shuljenko A.E.1
-
Affiliations:
- National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia
- Issue: Vol 18, No 4 (2021)
- Pages: 149-155
- Section: Case reports
- URL: https://rusalljournal.ru/raj/article/view/1494
- DOI: https://doi.org/10.36691/RJA1494
- ID: 1494
Cite item
Abstract
Chronic spontaneous urticaria is the spontaneous appearance of blisters, angioedema, or both for >6 weeks that affects up to 0.5%–5% of the population, mainly females. Spontaneous wheals and/or angioedema, severe skin itching that leads to depression and anxiety, sleep disturbances, sexual dysfunction, and activity of daily life and work restrictions. Other diseases sometimes occur under the guise of chronic spontaneous urticaria.
Urticarial vasculitis is a vasculitis of the small skin vessels, characterized by the duration of persistent skin rashes in combination with histopathological features of leukocytoclastic vasculitis. Differential diagnosis of chronic spontaneous urticaria and urticarial vasculitis is conducted in the case of an atypical clinical picture of urticaria. Wheals lasted for >24 h, often accompanied by burning and pain, and leaving behind purpura or residual hyperpigmentation.
Herein, described a case of urticarial vasculitis in a patient that required a differential diagnosis of chronic spontaneous urticaria and urticarial vasculitis several years after the disease onset. Successful treatment was conducted with a combination of antihistamines, glucocorticosteroids, hydroxychloroquine, and omalizumab.
Full Text

About the authors
Irina V. Dorofeeva
National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia
Email: idorofeeva1@gmail.com
ORCID iD: 0000-0002-4423-1797
SPIN-code: 5480-4193
Russian Federation, 24, Kashirskoyw shosse, Moscow, 115522
Inna V. Danilycheva
National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia
Email: ivdanilycheva@mail.ru
ORCID iD: 0000-0002-8279-2173
SPIN-code: 4547-3948
MD, Cand. Sci. (Med.)
Russian Federation, 24, Kashirskoyw shosse, Moscow, 115522Andrey E. Shuljenko
National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia
Author for correspondence.
Email: shulzhenko_ae@mail.ru
ORCID iD: 0000-0003-0268-9350
SPIN-code: 4584-4915
MD, Dr. Sci. (Med.), Professor
Russian Federation, 24, Kashirskoyw shosse, Moscow, 115522References
- Zuberbier T, Aberer W, Asero R, et al. The EAACI/ GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–1414. doi: 10.1111/all.13397
- Federal Clinical guidelines for the diagnosis and treatment of urticaria. Russian Association of Allergists and Clinical Immunologists; 2019. (In Russ).
- Guillén-Aguinaga S, Jáuregui Presa I, Aguinaga-Ontoso E, et al. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis. Br J Dermatol. 2016;175(6):1153–1165. doi: 10.1111/bjd.14768
- Maurer M, Staubach P, Raap U, et al. ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice. Br J Dermatol. 2016;174(4):892–894. doi: 10.1111/bjd.14203
- Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317–330. doi: 10.1111/j.1398-9995.2010.02496.x
- Eun S, Lee J, Kim D, Yoon H. Natural course of new-onset urticaria: results of a 10-year follow-up, nationwide, population-based study. Allergol Int. 2019;68(1):52–58. doi: 10.1016/j.alit.2018.05.011
- O’Donnell B, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197–201.
- Kozel M, Mekkes J, Bossuyt P, Bos J. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45(3):387–391. doi: 10.1067/mjd.2001.116217
- Van der Valk P, Moret G, Kiemeney L. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol. 2002;146(1):110–113. doi: 10.1046/j.1365-2133.2002.04582.x
- Thomsen SF, Pritzier EC, Anderson CD, et al. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the noninterventional multicentre AWARE study. JEADV. 2017;31(6):1048–1055. doi: 10.1111/jdv.14210
- Costa C, Rosmaninho I, Guilherme A, et al. Chronic urticaria in the real-life clinical practice setting in Portugal: baseline results from the non-interventional multicentre AWARE study. Acta Med Port. 2019;32(2):133–140. doi: 10.20344/amp.9496
- Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:42. doi: 10.1186/s13601-019-0278-3
- Tat T. Higher Levels of depression and anxiety in patients with chronic urticaria. Med Sci Monit. 2019;25:115–120. doi: 10.12659/MSM.912362
- Gonçalo M, Arnau GA, Al‐Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatology. 2021;184(2):226–236. doi: 10.1111/bjd.19561
- Caproni M, Verdelli A. An update on the nomenclature for cutaneous vasculitis. Curr Opin Rheumatol. 2019;31(1):46–52. doi: 10.1097/BOR.0000000000000563
- Kolkhir P, Grakhova M, Bonnekoh H, et al. Treatment of urticarial vasculitis: a systematic review. J Allergy Clin Immunol. 2019;143(2):458–466. doi: 10.1016/j.jaci.2018.09.007
- Kolkhir P, Bonnekoha H, Kocatürkc E, et al. Management of urticarial vasculitis: a worldwide physician perspective. World Allergy Organ J. 2020;13(3):100107. doi: 10.1016/j.waojou.2020.100107
- Dincy CV, George R, Jacob M, et al. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India. J Eur Acad Dermatol Venereol. 2008;22(7):789–794. doi: 10.1111/j.1468-3083.2007.02641.x
- O’Donnell B, Black AK. Urticarial vasculitis. Int Angiol. 1995;14(2):166–174.
- Cardoso PA, de Oliveira ZP, Alves VA, et al. Urticarial vasculitis. Allergol Immunopathol. 1990;18(4):191–195.
- Peteiro C, Toribio J. Incidence of leukocytoclastic vasculitis in chronic idiopathic urticaria. Study of 100 cases. Am J Dermatopathol. 1989;11(6):528–533. doi: 10.1097/00000372-198912000-00003
- Borzova E., Grattan С.E. Urticarial Vasculitis. In: Griffiths C.E., Barker J., Bleiker T.O., et al. Rook’s textbook of dermatology. Vol. 4 Set, 9th Edition. UK, Wiley Blackwell; 2016. Р. 44.1.
- Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol. 2000;12(1):24–31. doi: 10.1097/00002281-200001000-00005
- Mehregan DR, Gibson LE. Pathophysiology of urticarial vasculitis. Arch Dermatol. 1998;134(1):88-89. doi: 10.1001/archderm.134.1.88
- Kano Y, Orihara M, Shiohara T. Cellular and molecular dynamics in exercise‐induced urticarial vasculitis lesions. Arch Dermatol. 1998;134(1):62–67. doi: 10.1001/archderm.134.1.62
- Gammon WR. Urticarial vasculitis. Dermatol Clin. 1985;3(1):97–105.
- Danilycheva IV. Urticarian vasculitis: diagnostic algorithm. Doktor.Ru. 2009;2(46):67–72. (In Russ).
- Kolkhir PV. Urticar vasculitis. Urticaria and angioedema. Moscow: Practical Medicine; 2012. Р. 286–297. (In Russ).
- Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Alleergy Immunol. 2002;23(2):201–211. doi: 10.1385/CRIAI:23:2:201
- Dincy CV, George R, Jacob M, et al. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India. J Eur Acad Dermatol Venereol. 2008;22(7):789–794. doi: 10.1111/j.1468-3083.2007.02641.x
- Davis MD, Daoud MS, Kirby B, et al. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol. 1998;38(6 Pt 1):899–905.
- Kulthanan K, Cheepsomsong M, Jiamton S. Urticarial vasculitis: etiologies and clinical course. Asian Pac J Allergy Immunol. 2009;27(2-3):95–102.
- Schwartz HR, McDuffie FC, Black LF, et al. Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc. 1982;57(4):231–238.
- Jachiet M, Flageul B, Deroux A, et al. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol. 2015;67(2):527–534. doi: 10.1002/art.38956
- Tosoni C, Lodi-Rizzini F, Cinquini M, et al. A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients. Clin Exp Dermatol. 2009;34(2):166–170. doi: 10.1111/j.1365-2230.2008.02891.x
- Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am. 2004;24(2):183–213. doi: 10.1016/j.iac.2004.01.007
- Grotz W, Baba HA, Becker JU, Baumgartel MW. Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int. 2009;106(46):756–763. doi: 10.3238/arztebl.2009.0756
- Sunderkotter C, Bonsmann G, Sindrilaru A, Luger T. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005;16(4):193–206. doi: 10.1080/09546630500277971
- Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis. Int J Dermatol. 1988;27(7):468–472. doi: 10.1111/j.1365-4362.1988.tb00921.x
- Chen YD, Krause K, Tu P, et al. Response of omalizumab in normocomplementemic urticarial vasculitis. J Allergy Clin Immunol Pract. 2020;8(6):2114–2117. doi: 10.1016/j.jaip.2020.02.024
- De Brito M, Huebner G, Murrell D, et al. Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab. Clin Transl Allergy. 2018;8:37. doi: 10.1186/s13601-018-0222-y
- Rattananukrom T, Svetvilas P, Chanprapaph K. Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: a report of three cases and literature review. Asian Pac J Allergy Immunol. 2020;38(4):286–289. doi: 10.12932/AP-050918-0402
Supplementary files
